Glycinorm-M XR Forte Tablet
By Glycinorm-M
Rx
15 Tablet in a Strip

Composition
Gliclazide(60mg) + Metformin(1000mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
July, 2026

liver
It is important to be cautious when using Glycinorm-M XR Forte Tablet in patients with liver disease. Patients with liver issues may require a dose adjustment for this medication. It is advisable to consult your doctor before starting treatment. Glycinorm-M XR Forte Tablet is usually initiated at a low dose for individuals with mild to moderate liver disease. However, it is not recommended for patients with severe liver disease. Prior to prescribing Carryl M 60 mg Forte Tablet 10's, inform your doctor if you have a history of liver diseases. Your doctor may need to make changes to your dosage based on the current condition of your liver.

kidney
Glycinorm-M XR Forte Tablet should be used carefully in patients with kidney disease. Dose adjustment may be necessary; consult your doctor. Avoid using this tablet in severe kidney disease. Regular kidney function tests are recommended during treatment. Inform your doctor of any history of kidney conditions before taking this medication.

alcohol
It is not safe to drink alcohol while taking Glycinorm-M XR Forte Tablet. Avoid consuming alcohol to prevent any unwanted side effects.

driving
When taking Glycinorm-M XR Forte Tablet, be mindful of potential hypoglycemia symptoms like sleepiness, shivering, palpitations, and sweating. Avoid driving if experiencing these effects as they may impair your ability to focus. Use caution when operating vehicles or doing tasks that need concentration.

pregnancy
Glycinorm-M XR Forte Tablet should not be used during pregnancy as it poses risks to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before use, as there are no well-controlled studies on pregnant women.

breastfeeding
Caution should be exercised when considering breastfeeding while using Glycinorm-M XR Forte Tablet. Limited evidence indicates potential risk to the baby through breastmilk. Consulting your doctor before use is advisable to assess the safety for nursing mothers.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹238.6
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024